Despite these caveats, the direction and consistency of effect estimates across multiple analytic approaches (HR range: 2.19–2.86) suggest a possible trend toward inferior survival in the (C)RT-based group.
← all excerpts
Tumor stage and treatment outcomes in external auditory canal SCC: a multicenter cohort study.
2
—
—
The sentences
Concurrent cisplatin dosing ≥300 mg during radiotherapy was associated with a trend toward improved survival, though the effect did not reach statistical significance.